← SynDRA
ETOFIBRATE
SynDRA canonical compound SYN0005130 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | LPL | PPARA |
|---|
| Mechanism of action | PPAR receptor agonist |
|---|
| Indication | hypertriglyceridemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- PPAR receptor agonist
- Platelet aggregation inhibitor
- Lipase clearing factor inhibitor
- PPARA AGONIST
- Peroxisome proliferator-activated receptor alpha agonist
- LPL ACTIVATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- OPRD1
- HRH3
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRK1
- ADORA2A
- OPRM1
- PDE3A
- PDE4D
- PGR
- PPARG
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HRH2
- HRH1
- HDAC6
- GHSR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
Drug classes
- Anticholesteremic Agents
- Antimetabolites
- Hypolipidemic Agents
- Lipid Regulating Agents
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Peripheral Nervous System Agents
- Respiratory System Agents
- Antioxidants
- Protective Agents
- Radiation-Sensitizing Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- etofibrate hydrochloride
- etofibrate HCl
- ethofibrate
- tricerol
- Etofibrato
- Etofibratum
- RefChem:139269
- C10AB09
- DTXCID20108012
- Etofibrate [INN]
- MFCD00865727
- Etofibrate (INN)
- Etofibratum [INN-Latin]
- Etofibrato [INN-Spanish]
- EINECS 250-743-1
- UNII-23TF67G79M
- Ethofibrate?
- XXRVYAFBUDSLJX-UHFFFAOYSA-N
- ETOFIBRATE [MI]
- ETOFIBRATE [MART.]
- SCHEMBL3122
- ETOFIBRATE [WHO-DD]
- MLS006010106
- Etofibrate, analytical standard
- orb1305322
- SCHEMBL29801484
- CHEBI:135535
- GLXC-06147
- HMS3652N04
- HMS5082B22
- HY-A0127
- AKOS025311314
- CCG-268206
- AC-23121
- AS-16847
- SMR002529563
- SY102266
- CS-0017444
Look up ETOFIBRATE in the interactive SynDRA portal →